(2S,3S,4S,5R,6S)-6-[2-[(3S)-3-[[(2S)-7-[[1-[3-[[(2S)-1-[[(2S)-1-[2-[(2S,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-4-[[2-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-10-yl]ethyl-propan-2-ylcarbamoyl]oxymethyl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-oxopropyl]-2-[[methyl(methylamino)amino]methyl]indol-5-yl]amino]-4,7-dioxo-2-propan-2-ylheptanoyl]amino]-2-oxobutyl]-5-[[2-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-8-yl]ethyl-propan-2-ylcarbamoyl]oxymethyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
C114H134N14O33 — CID 167550850
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,3S,4S,5R,6S)-6-[2-[(3S)-3-[[(2S)-7-[[1-[3-[[(2S)-1-[[(2S)-1-[2-[(2S,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-4-[[2-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-10-yl]ethyl-propan-2-ylcarbamoyl]oxymethyl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-oxopropyl]-2-[[methyl(methylamino)amino]methyl]indol-5-yl]amino]-4,7-dioxo-2-propan-2-ylheptanoyl]amino]-2-oxobutyl]-5-[[2-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-8-yl]ethyl-propan-2-ylcarbamoyl]oxymethyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
(2S,3S,4S,5R,6S)-6-[2-[(3S)-3-[[(2S)-7-[[1-[3-[[(2S)-1-[[(2S)-1-[2-[(2S,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-4-[[2-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-10-yl]ethyl-propan-2-ylcarbamoyl]oxymethyl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-oxopropyl]-2-[[methyl(methylamino)amino]methyl]indol-5-yl]amino]-4,7-dioxo-2-propan-2-ylheptanoyl]amino]-2-oxobutyl]-5-[[2-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-8-yl]ethyl-propan-2-ylcarbamoyl]oxymethyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid (PubChem CID 167550850) has the molecular formula C114H134N14O33 and a molecular weight of 2228.39 g/mol. Its IUPAC name is (2S,3S,4S,5R,6S)-6-[2-[(3S)-3-[[(2S)-7-[[1-[3-[[(2S)-1-[[(2S)-1-[2-[(2S,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-4-[[2-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-10-yl]ethyl-propan-2-ylcarbamoyl]oxymethyl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-oxopropyl]-2-[[methyl(methylamino)amino]methyl]indol-5-yl]amino]-4,7-dioxo-2-propan-2-ylheptanoyl]amino]-2-oxobutyl]-5-[[2-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-8-yl]ethyl-propan-2-ylcarbamoyl]oxymethyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid.
Molecular Properties
| Compound Name | (2S,3S,4S,5R,6S)-6-[2-[(3S)-3-[[(2S)-7-[[1-[3-[[(2S)-1-[[(2S)-1-[2-[(2S,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-4-[[2-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-10-yl]ethyl-propan-2-ylcarbamoyl]oxymethyl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-oxopropyl]-2-[[methyl(methylamino)amino]methyl]indol-5-yl]amino]-4,7-dioxo-2-propan-2-ylheptanoyl]amino]-2-oxobutyl]-5-[[2-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-8-yl]ethyl-propan-2-ylcarbamoyl]oxymethyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid |
|---|---|
| PubChem CID | 167550850 |
| Molecular Formula | C114H134N14O33 |
| Molecular Weight | 2228.39 g/mol |
| Exact Mass | 2226.92 |
| IUPAC Name | (2S,3S,4S,5R,6S)-6-[2-[(3S)-3-[[(2S)-7-[[1-[3-[[(2S)-1-[[(2S)-1-[2-[(2S,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-4-[[2-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-10-yl]ethyl-propan-2-ylcarbamoyl]oxymethyl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-oxopropyl]-2-[[methyl(methylamino)amino]methyl]indol-5-yl]amino]-4,7-dioxo-2-propan-2-ylheptanoyl]amino]-2-oxobutyl]-5-[[2-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-8-yl]ethyl-propan-2-ylcarbamoyl]oxymethyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid |
| SMILES | CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CCN(C(=O)OCc4ccc(CC(=O)[C@H](C)NC(=O)[C@@H](CC(=O)CCC(=O)Nc5ccc6c(c5)cc(CN(C)NC)n6CCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)Nc5ccc(COC(=O)N(CCc6c7c(nc8ccccc68)-c6cc8c(c(=O)n6C7)COC(=O)[C@]8(O)CC)C(C)C)cc5O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O)C(C)C)C(C)C)c(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O)c4)C(C)C)cccc3nc2-1 |
| InChI | InChI=1S/C114H134N14O33/c1-15-113(152)76-45-82-90-65(47-127(82)103(142)74(76)52-154-109(113)148)42-72-62(20-19-23-79(72)119-90)32-35-124(56(7)8)111(150)156-50-60-24-26-63(85(38-60)158-107-96(137)92(133)94(135)98(160-107)105(144)145)43-84(130)58(11)116-101(140)71(54(3)4)44-68(129)28-31-87(131)118-66-27-30-81-64(40-66)41-67(48-123(14)115-13)126(81)37-34-88(132)122-89(55(5)6)102(141)117-59(12)100(139)121-80-29-25-61(39-86(80)159-108-97(138)93(134)95(136)99(161-108)106(146)147)51-157-112(151)125(57(9)10)36-33-69-70-21-17-18-22-78(70)120-91-73(69)49-128-83(91)46-77-75(104(128)143)53-155-110(149)114(77,153)16-2/h17-27,29-30,38-42,45-46,54-59,71,89,92-99,107-108,115,133-138,152-153H,15-16,28,31-37,43-44,47-53H2,1-14H3,(H,116,140)(H,117,141)(H,118,131)(H,121,139)(H,122,132)(H,144,145)(H,146,147)/t58-,59-,71-,89-,92-,93-,94-,95-,96+,97+,98-,99-,107+,108+,113-,114-/m0/s1 |
| InChIKey | CJNIYJOXZBPJMI-KVCCKYGHSA-N |
| XLogP | 5.66 |
| TPSA | 654.66 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 44 |
| Heavy Atoms | 161 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2228.39 |
| LogP ≤ 5 | 5.66 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 38 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167550850 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.